Sign In
Buy VRPX
$0.0008
+0 (+0%)
At Close: Jun 22, 2026
Virpax Pharmaceuticals Earnings Calls
Mar 31, 2026
(Upcoming)
| Release date | Aug 11, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 10.28% |
Dec 31, 2025
| Release date | Mar 24, 2026 |
| EPS estimate | -$2.75 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Mar 30, 2025
| Release date | May 12, 2025 |
| EPS estimate | - |
| EPS actual | -$68.75 |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
-$0.80 (-196.30%)
| Release date | Mar 03, 2025 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.80 |
| EPS Surprise | -196.30% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Virpax Pharmaceuticals
Below you can see how VRPX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
Missed
| Release date | Mar 03, 2025 |
| Price on release | $4.96 |
| EPS estimate | -$0.270 |
| EPS actual | -$0.80 |
| EPS surprise | -196.30% |
| Date | Price |
|---|---|
| Feb 25, 2025 | $6.13 |
| Feb 26, 2025 | $5.99 |
| Feb 27, 2025 | $5.68 |
| Feb 28, 2025 | $6.00 |
| Mar 03, 2025 | $4.96 |
| Mar 04, 2025 | $4.75 |
| Mar 05, 2025 | $4.85 |
| Mar 06, 2025 | $4.68 |
| Mar 07, 2025 | $4.84 |
| 4 days before | -19.09% |
| 4 days after | -2.42% |
| On release day | -4.28% |
| Change in period | -21.04% |
Mar 30, 2025
| Release date | May 12, 2025 |
| Price on release | $0.235 |
| EPS estimate | - |
| EPS actual | -$68.75 |
| Date | Price |
|---|---|
| May 06, 2025 | $0.270 |
| May 07, 2025 | $0.243 |
| May 08, 2025 | $0.245 |
| May 09, 2025 | $0.238 |
| May 12, 2025 | $0.235 |
| May 13, 2025 | $0.240 |
| May 14, 2025 | $0.240 |
| May 15, 2025 | $0.250 |
| May 16, 2025 | $0.220 |
| 4 days before | -12.89% |
| 4 days after | -6.46% |
| On release day | 2.04% |
| Change in period | -18.52% |
Dec 31, 2025
| Release date | Mar 24, 2026 |
| Price on release | $0.0110 |
| EPS estimate | -$2.75 |
| EPS actual | - |
| Date | Price |
|---|---|
| Mar 18, 2026 | $0.0110 |
| Mar 19, 2026 | $0.0110 |
| Mar 20, 2026 | $0.0110 |
| Mar 23, 2026 | $0.0110 |
| Mar 24, 2026 | $0.0110 |
| Mar 25, 2026 | $0.0110 |
| Mar 26, 2026 | $0.0110 |
| Mar 27, 2026 | $0.0110 |
| Mar 30, 2026 | $0.0110 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Mar 31, 2026
(Upcoming)
| Release date | Aug 11, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $0.0008 |
| Jun 16, 2026 | $0.0008 |
| Jun 17, 2026 | $0.0008 |
| Jun 18, 2026 | $0.0008 |
| Jun 22, 2026 | $0.0008 |
Virpax Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for VRPX?
Virpax Pharmaceuticals, Inc. (VRPX) has scheduled its earnings report for Aug 11, 2026 after the markets close.
What is the VRPX price-to-earnings (P/E) ratio?
VRPX P/E ratio as of Jun 22, 2026 (TTM) is -0.0039.
What is the VRPX EPS forecast?
The forecasted EPS (Earnings Per Share) for Virpax Pharmaceuticals, Inc. (VRPX) for the first fiscal quarter 2026 is $.
What are Virpax Pharmaceuticals, Inc.'s retained earnings?
On its balance sheet, Virpax Pharmaceuticals, Inc. reported retained earnings of $0 for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
